An image database for better diagnosis and treatment of cancer patients has been unveiled by Strand Scientific Intelligence of Strand Life Sciences.
The city-based Strand subsidiary developed the Curie Image Database (CID), an image analysis and management platform, with the Paris-based Curie-Cancer of Institut Curie, a private foundation formed by Marie Curie (1867-1935) - the first women Nobel laureate.
Cancer Key Facts and Statistics
Cancer is an abnormal cell growth and it can destroy other body tissues. 1 in 6 deaths that occur in the world is due to cancer. Here are some key facts and statistics about cancer
Advertisement
"We have developed the image database using our Avadis platform to enable 250 scientists at Institut Curie and 10 other collaborating institutions across Europe to manage heterogeneous imaging data and complex analysis workflows," Strand chief executive Vijay Chandru said in a statement here.
Strand has built an advanced genome sequencing-based diagnostic platform for oncology.
"We will also explore with Institute Curie an advanced platform that integrates genomic signatures of cancers and imaging data for better diagnosis and treatment of cancer patients," Chandru said.
![Quiz on Ovarian Cancer / Cancer of the Ovary]( "Quiz on Ovarian Cancer / Cancer of the Ovary")
Ovarian cancer is a cancer that does not produce definite symptoms. Here are a few questions that you could attempt to answer to check your knowledge on ovarian cancer.
As an image management system and an interactive research tool, the CID will allow data and analysis sharing for multidisciplinary projects between teams from different labs and institutes.
"The database will be able to handle the exponential growth and complexity of scientific and biomedical images generated by advanced microscopy systems," said Jean Salamero, scientific director of cell and tissue imaging facility at Curie-Cancer.
Funding by a French network of institutions enabled the partners (Strand & Curie) to link the database to a secure storage infrastructure for image processing on dedicated clusters.
"We have contributed to the technology developed by Strand, whose roots are in India, as such a partnership project may help treatment of cancer," Curie-Cancer director Damien Saluze said in the statement.
Source: IANS
"We will also explore with Institute Curie an advanced platform that integrates genomic signatures of cancers and imaging data for better diagnosis and treatment of cancer patients," Chandru said.
Quiz on Ovarian Cancer / Cancer of the Ovary
Ovarian cancer is a cancer that does not produce definite symptoms. Here are a few questions that you could attempt to answer to check your knowledge on ovarian cancer.
Advertisement
As an image management system and an interactive research tool, the CID will allow data and analysis sharing for multidisciplinary projects between teams from different labs and institutes.
"The database will be able to handle the exponential growth and complexity of scientific and biomedical images generated by advanced microscopy systems," said Jean Salamero, scientific director of cell and tissue imaging facility at Curie-Cancer.
Funding by a French network of institutions enabled the partners (Strand & Curie) to link the database to a secure storage infrastructure for image processing on dedicated clusters.
"We have contributed to the technology developed by Strand, whose roots are in India, as such a partnership project may help treatment of cancer," Curie-Cancer director Damien Saluze said in the statement.
Source: IANS
World Cancer Death Clock
World Cancer Death Clock is a dynamic calculator that constantly updates the number of people in the world dying due to various cancers.
Advertisement
 Study Suggests Fusion of Macrophages With Cancer Cells may Aid in Their Spread to Other Areas of the BodyA new study suggests that spontaneous fusing of cancer cells with the immune system's scavenger cells could play a key role in the spread of the cancer. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
